Today, investors in Chinese fintech stocks are bleeding red, as both FUTU stock and TIGR stock see dramatic declines this afternoon. More
Articles
Ginkgo Bioworks Price Predictions: Why One Analyst Thinks Hard-Hit DNA Stock Can Hit $14.50
Today, a bullish analyst price target placed on Ginkgo Bioworks has sent DNA stock on a nice ride as investors pile into this growth play. More
PAVM Stock: One Big Reason Why PAVmed Is Plunging Today
Today, a relatively disappointing start to trading for a PAVmed subsidiary, Lucid Diagnostics, is driving some bearish price action. More
Lightning eMotors Is a Bargain With Exciting Future Prospects
ZEV stock shouldn't stay down for much longer as Berkshire-backed Lightning eMotors secures a lucrative delivery contract abroad. More
LUCD Stock IPO: 7 Things to Know as Lucid Diagnostics Starts Trading Today
Unfortunately, today is a very red day for investors who got in on the recent LUCD stock IPO, with shares of this stock down more than 17%. More
